Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fc effector cross-reactivity: A hidden arsenal against SARS-CoV-2's evasive maneuvering.

Cell reports. Medicine - 15 Feb 2022

Grunst Michael W, Uchil Pradeep D

Abstract excerpt

It is unclear whether SARS-CoV-2 VOCs differentially escape Fc effector functions of antibodies in addition to neutralization. In this issue of Cell Reports Medicine, Richardson et al.1 show that VOCs differ both in their ability to evade as well as elicit cross-reactive Fc-effector functions.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross Reactions

Share to Immune Evasion

Share to Immunoglobulin Fc Fragments

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 35233551
DOI: 10.1016/j.xcrm.2022.100540
PMCID: PMC8823971

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Fc effector cross-reactivity: A hidden arsenal against SARS-CoV-2's evasive maneuvering.PMID 35233551Read ↗

A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivitySemantic proximity Read ↗

SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivitySemantic proximity Read ↗

Therapeutic Potential of SARS-CoV-2-Specific Monoclonal Antibody CR3022Semantic proximity Read ↗

Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infectionSemantic proximity Read ↗

Research progress in Fc-effector functions against SARS-CoV-2Semantic proximity Read ↗

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionSemantic proximity Read ↗

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2Semantic proximity Read ↗

ACE2 decoy Fc-fusions and bi-specific killer engager (BiKEs) require Fc engagement for <i>in vivo</i> efficacy against SARS-CoV-2Semantic proximity Read ↗

Fc-independent neutralization of SARS-CoV-2 by recombinant human monoclonal antibodiesSemantic proximity Read ↗

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronavirusesSemantic proximity Read ↗

The neonatal Fc receptor (FcRn) is a pan-arterivirus receptorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.